ARS Pharmaceuticals, Inc. Ratios

Ratios Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin -353.32%-2,698.78%-181,216.67%9.29%
EBIT Margin -353.32%-2,698.78%-225,066.67%-3.46%
EBITDA Margin -367.65%-2,604.48%-182,410.00%9.16%
Operating Margin -353.32%-2,698.78%-225,066.67%-3.46%
Net Margin -353.32%-2,698.78%-181,216.67%8.97%
FCF Margin -319.94%-3,060.56%-198,136.67%14.57%
Efficiency
Assets Average 171.44M257.31M292.17M
Equity Average 120.81M251.82M243.78M
Invested Capital -31.27M272.89M230.76M256.80M
Asset Utilization Ratio 0.010.000.31
Leverage & Solvency
Debt to Equity -0.16
Debt Ratio 0.08
Equity Ratio -0.510.970.990.73
Valuation
Enterprise Value 173.54M33.20M297.70M711.28M
Market Capitalization 233.61M307.58M526.06M1,025.31M
Return Ratios
Return on Sales -3.53%-26.99%0.09%
Return on Capital Employed -0.21%-0.26%-0.01%
Return on Invested Capital -0.01%
Return on Assets -0.21%-0.21%0.03%
Return on Equity -0.29%-0.22%0.03%